Our whole exome sequencing delivers
- Mean read depth of >160x
- Exome coverage of >98% at 20x
- Mitochondrial genome results with mean read depth of 6800x
- Validated CNV evaluation down to 1 exon
For over 40 years, Quest Diagnostics has worked to take what was once rare or highly frictional and make it an accessible, seamless part of cross-clinical patient care. Our Quest Diagnostics Genomics team is dedicated to bridging clinical gaps and simplifying how you deliver advanced care.
Whether at our booth (1177) or poster sessions, let’s discuss how we can support your practice with direct expert access, seamless EMR workflows, and broad coverage that protects your patients. Together, we can make confident genetic insights an accessible reality across your entire care continuum.
We look forward to connecting with you!
Learn from our experts on topics such as
From in-person to on-demand, see our calendar of sessions below. We can't wait to see you there!
On Wednesday, November 18, join us for an insightful webinar as Emily Partack and Rebecca Johnson explore the critical role of whole exome sequencing (WES). They will share compelling case studies and clinical experiences that show the power of exome testing in action. You will also receive practical, guideline-driven insights to incorporate WES into your workflow.
This webinar covers
Rebecca Johnson Wheeler, MS, CGC, explores how whole exome sequencing and Quest Diagnostics genetic experts are transforming rare disease diagnosis by enabling earlier answers, reducing unnecessary testing, and improving care for patients and families.
This podcast covers
Rebecca Johnson Wheeler, MS, CGC, and Steve Keiles, MS, CGC, discuss how advances in WES, growing insurance coverage, and expanding clinical applications are helping patients get answers faster while improving targeted treatment and care.
This podcast covers